Skip to main content
Abliva logo

Abliva — Investor Relations & Filings

Ticker · ABLI ISIN · SE0002575340 LEI · 5493005YV22OTMUHZ183 ST Manufacturing
Open in API
Filings indexed 594 across all filing types
Latest filing 2015-03-18 Report Publication Anno…
Country SE Sweden
Listing ST ABLI

About Abliva

https://abliva.com

Abliva is a biopharmaceutical company that discovers and develops medicines for the treatment of primary mitochondrial diseases. These are rare, congenital, and often severe genetic disorders that occur when the cell's energy converters, the mitochondria, are dysfunctional. The company's research and development is focused on creating novel therapies aimed at restoring mitochondrial function and addressing the significant unmet medical needs of patients. Abliva's primary goal is to deliver treatments that provide meaningful clinical benefits for individuals suffering from these debilitating conditions.

Recent filings

Filing Released Lang Actions
Report Publication Announcement 2015
Report Publication Announcement Classification · 1% confidence The document text explicitly states: "NeuroVive Pharmaceutical publishes English version of annual report for 2014" and then immediately follows up with "The annual report can also be accessed via the below link." The document itself is very short (1720 characters) and serves only to announce the availability of the full annual report, rather than containing the full content of the 2014 Annual Report (which would typically be classified as 10-K if it were the full filing, or IR if it were a comprehensive interim report). According to Rule 2, when a document is short and announces the publication of a report, it should be classified as a Report Publication Announcement (RPA).
2015-03-18 English
Report Publication Announcement 2015
Report Publication Announcement Classification · 1% confidence The document text is very short (1152 characters) and explicitly states that the 'årsredovisningen för 2013' (Annual Report for 2013) is now available on the company website and can be read via a link. This structure—announcing the availability of a full report rather than containing the full report itself—fits the definition of a Report Publication Announcement (RPA). Although the title mentions 'årsredovisningen' (Annual Report), the content is purely an announcement of its publication, triggering the 'MENU VS MEAL' rule.
2015-03-06 Swedish
Major Shareholding Notification 2015
Major Shareholding Notification Classification · 1% confidence The document details a change in shareholding ('Major shareholding notification') by Baulos Capital Belgium SA in Abliva AB (referred to as Neurovive in the notes). It explicitly states the 'Reason for major shareholding notification' and provides the 'Before' and 'After' transaction details, including the resulting percentage (14.32%). This directly corresponds to the definition of a Major Shareholding Notification, which is classified as 'MRQ' (Major Shareholding Notification). The document structure, focusing on thresholds and resulting ownership percentages, confirms this classification.
2015-03-04 English
Major Shareholding Notification 2015
Major Shareholding Notification Classification · 1% confidence The document details a change in shareholding for 'Baulos Capital Belgium SA' in 'Abliva AB'. It explicitly shows the 'Before the transaction' and 'After the transaction' holdings, including the quantity of shares (2,560,000) and the resulting percentage (9.21%). The structure and content perfectly match the definition of a Major Shareholding Notification, which reports changes in significant ownership levels crossing thresholds. This corresponds to the filing type code MRQ.
2015-02-25 English
Notice of Annual General Meeting of NeuroVive Pharmaceutical AB (publ)
AGM Information Classification · 1% confidence The document is explicitly titled "Notice of Annual General Meeting of NeuroVive Pharmaceutical AB (publ)" and details the date, time, location, registration procedures, proposed agenda items (including election of chairman, approval of accounts, election of directors, and remuneration guidelines), and proposed resolutions for the meeting. This content perfectly matches the definition of materials shared during an Annual General Meeting (AGM). Therefore, the classification is AGM-R.
2015-02-25 English
Kallelse till årsstämma i NeuroVive Pharmaceutical AB (publ)
AGM Information Classification · 1% confidence The document is titled "Kallelse till årsstämma i NeuroVive Pharmaceutical AB (publ)" which translates to "Notice of Annual General Meeting in NeuroVive Pharmaceutical AB (publ)". It details the date, time, location, registration procedures, proposed agenda items (including election of chairman, approval of annual report, remuneration guidelines, and authorization for new share issues), and specific proposals to be voted upon at the meeting. This content is characteristic of a formal notice calling shareholders to an Annual General Meeting (AGM). Therefore, the appropriate classification is AGM-R (AGM Information).
2015-02-25 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.